Humana has signed a definitive agreement to buy hospice pharmacy and pharmacy benefits manager Enclara Healthcare, according to Forbes.
The move is part of Humana's plan to expand its outpatient medical care for seniors.
The insurance giant will acquire Enclara form Consonance Capital Partners for an undisclosed sum.
"Enclara represents a logical extension of Humana pharmacy’s strategy given the company’s unique ability to play a role in advanced illness care and supplement our existing care delivery system," Scott Greenwell, PharmD, Humana’s president of pharmacy solutions, told Forbes.
Humana joins a growing number of insurers partnering with healthcare providers and luring patients from unaffiliated physicians and clinics. UnitedHealth Group's purchase of Optum and CVS Health's purchase of Aetna are two other such deals.
Enclara told Forbes it serves more than 450 hospice providers and 97,000 hospice patients daily.
The acquisition is expected to close in the first half of 2020.
Read the full article here.
More articles on pharmacy:
House passes Pelosi's drug pricing bill, with a few changes
Walmart agrees to continue accepting paper prescriptions
Sienna Biopharmaceuticals to shut down by end of week